Alla Polozova, PhD Amgen Inc.

Dr. Polozova has been with Amgen, Inc. since 2013 in the Process Development / Attribute Sciences department. She served as Attribute Sciences Team Leader for commercial and late stage protein therapeutics and managed a group within Pivotal Attribute Sciences supporting characterization testing, as well as methods development, qualification, transfer and validation. Most recently Dr. Polozova led preparation of CMC analytical characterization packages for marketing applications of two Amgen biosimilar candidates. Prior to joining Amgen, Dr. Polozova held positions in MedImmune/AstraZeneca, NIH and Liposome Company/Elan.